Reported Earnings • 35m
Full year 2026 earnings released: EPS: kr2.93 (vs kr2.92 in FY 2025) Full year 2026 results: EPS: kr2.93 (up from kr2.92 in FY 2025). Revenue: kr3.65b (up 9.9% from FY 2025). Net income: kr563.8m (flat on FY 2025). Profit margin: 16% (down from 17% in FY 2025). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Healthcare Services industry in Europe. Over the last 3 years on average, earnings per share has increased by 16% per year whereas the company’s share price has increased by 20% per year. Declared Dividend • Jun 08
Dividend of kr2.30 announced Shareholders will receive a dividend of kr2.30. Ex-date: 9th September 2026 Payment date: 15th September 2026 Dividend yield will be 8.9%, which is higher than the industry average of 0.9%. Sustainability & Growth Dividend is well covered by both earnings (44% earnings payout ratio) and cash flows (49% cash payout ratio). The dividend has increased by an average of 17% per year over the past 6 years and payments have been stable during that time. EPS is expected to grow by 86% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Announcement • Jun 06
Sectra AB (Publ) Proposes an Ordinary Dividend Sectra AB (publ) proposed that the 2026 AGM resolve on an ordinary dividend of SEK 1.30 (1.10) per share, considering the year's cash flow and Sectra's financial position. In addition, it is proposed that the Board be authorized to decide on the acquisition of own shares (see the year-end report) in order to enable the repurchase of Class B shares to secure the company's commitments under a new share-based incentive program that the Board intends to propose to the AGM. Announcement • May 23
Sectra AB (publ), Annual General Meeting, Sep 08, 2026 Sectra AB (publ), Annual General Meeting, Sep 08, 2026. Announcement • Apr 17
Sectra AB (publ) (OM:SECT B) completed the acquisition of Oxipit, UAB. Sectra AB (publ) (OM:SECT B) entered into an agreement to acquire Oxipit, UAB on March 5, 2026. The acquisition will be funded from Sectra own funds and comprises an upfront cash consideration and an additional contingent consideration linked to commercial and regulatory milestones. The transaction is subject to customary closing conditions.
The transaction is expected to complete in March 2026.
Sectra AB (publ) (OM:SECT B) completed the acquisition of Oxipit, UAB on April 15, 2026. With the acquisition complete, Sectra now owns and will further develop ChestLink, Oxipit's flagship product and one of the most clinically validated examples of autonomous AI in radiology. This milestone strengthens Sectra's position as a provider of advanced, regulatory-approved AI solutions for diagnostic imaging. Announcement • Mar 10
Sectra Showcases MCP-Powered AI Innovations To Accelerate Enterprise Imaging At HIMSS Sectra showcased AI-driven solutions and Model Context Protocol (MCP)-powered prototypes at HIMSS 2026 designed to automate workflows and reduce operational complexity. By focusing on system consolidation, interoperability, seamless AI integration, and built-in multi-specialty reporting capabilities, Sectra's solutions accelerate diagnostics, reduce costs, and ease physician workload - enabling faster and better diagnoses. Sectra will demonstrate MCP, an emerging open standard gaining traction across industries, designed to simplify how AI integrates across enterprise imaging and integrated diagnostics, including genomics. The solution opens the door to a new paradigm for interfacing in medical IT. By leveraging MCP to power AI-driven interactions and interfaces, Sectra can automate workflows such as modality configuration, user role management, data analysis, and integration setup. This streamlines IT operations, reduces risk, and frees up resources to focus on patient-centered care. Examples of current and upcoming AI-driven capabilities include: AI for operations: Automates complex IT tasks using Operations AI powered by MCP, reducing manual effort and improving system efficiency. AI for workflows: Sectra's Amplifier Services marketplace features +100 validated AI applications for triaging, prioritization, and more, integrated seamlessly into workflows. AI for diagnostics: Empowers clinicians with tools like lesion segmentation, pathology cell counting, and automated chest X-ray analysis to enhance speed and accuracy. Autonomous AI in radiology: With the previously announced acquisition of Oxipit (closing expected March 2026), Sectra advances its autonomous AI capabilities in diagnostic imaging. Oxipit holds the first CE Class IIb certification for autonomous AI in chest X-ray analysis. This capability allows high-confidence normal cases to be cleared without radiologist review, initially in Europe, unlocking meaningful efficiency gains and cost reductions in healthcare. Sectra's enterprise imaging solution provides a unified platform for diagnostics needs based on large and unstructured data sets, such as imaging and genomics, enabling seamless collaboration across specialties such as radiology, pathology, genomics, and cardiology. After structuring the data, it is automatically forwarded into the EMR. Its scalable and modular design allows healthcare providers to expand from ology to ology and enterprise to enterprise while lowering operational costs and simplifying the adoption of AI. Announcement • Mar 06
Sectra AB (publ) (OM:SECT B) entered into an agreement to acquire Oxipit, UAB. Sectra AB (publ) (OM:SECT B) entered into an agreement to acquire Oxipit, UAB on March 5, 2026. The acquisition will be funded from Sectra own funds and comprises an upfront cash consideration and an additional contingent consideration linked to commercial and regulatory milestones. The transaction is subject to customary closing conditions.
The transaction is expected to complete in March 2026. Announcement • Nov 26
Sectra Launches Its Built-In Reporting Solution in the Us-Accelerates Diagnostics for Improved Patient Care Sectra is introducing its built-in reporting solution for medical imaging, Sectra Reporting, to the US market. By unifying image review and reporting together in the diagnostic workflow, radiologists can work in a single application and avoid switching between systems. This shortens turnaround times, reduces workload, and supports faster care delivery. Sectra Reporting is a native, built-in solution that streamlines diagnostic workflows by integrating directly with imaging data and measurements. To free up time for the radiologist to focus on diagnostics rather than on documentation, the solution has AI capabilities such as automated impression generation and external AI results seamlessly integrated. At the same time, deep links to measurements, annotations, and lesion-tracking data allow radiologists to embed precise, actionable references in the report. Another vital part within reporting is to provide the radiologist with instant access to relevant image content. This reduces manual steps, minimizes dictation errors, and clarifies clinical results. Sectra's reporting solution also lowers cognitive load through automatic linking of prior exams and improves safety by preventing incorrect references. While maintaining support for third-party reporting solutions, Sectra offers customers the choice of a streamlined experience designed to accelerate reporting and enhance clinical collaboration. Announcement • Nov 24
Sectra to Present New Developments Designed to Make Radiology Workflows Even More Efficient by Deep Integration with AI Sectra will present new developments designed to make radiology workflows even more efficient, not least by deep integration with AI. Sectra will showcase its entire enterprise imaging solution that provides a unified platform for all imaging needs-while offering unique CT features, subspecialty-specific workflows, and seamless AI adoption that help radiologists work efficiently and maintain diagnostic precision. In booth #8113, Sectra will showcase its complete enterprise imaging portfolio comprised of diagnostic modules (radiology, cardiology, pathology, orthopaedics, ophthalmology, and genomics), with its VNA and PACS at its core. In the latest KLAS report for customer satisfaction, Sectra's PACS was placed first for the 12th consecutive year and the KLAS Research surveys indicate that Sectra is the preferred choice among large US customers, with almost twice the rate of the second-ranked vendor. The enterprise imaging solution is delivered as a Software as a Service, independently audited and certified for cloud security by the Cloud Security Alliance (CSA). Selected highlights featured at Sectra's booth #8113 at RSNA include: Sectra's integrated reporting: New AI features in reporting to remove manual steps. Radiologists can dictate freely and automatically generate formatted impressions directly in the report, allowing for focus on diagnostics rather than documentation. Sectra's AI solutions: AI as a Service to accelerate adoption of AI in efficient clinical workflows. Healthcare providers can buy, activate and use validated algorithms quickly, allowing them to realize value from AI sooner. Sectra's PACS integrated photon-counting CT support: Integrated PCCT post-processing in the diagnostic application to deliver superior image clarity, lower patient radiation dose, and accelerate acquisition, allowing radiologists to diagnose confidently while streamlining workflow. Sectra's integrated clinical education portal: Sectra Education Portal to enhance learning for radiologists and radiographers. It provides a realistic imaging training environment with a diagnostic toolbox and access to personal or shared case libraries, supporting continuous skill development. Sectra Enterprise Research: A multi-modality solution that streamlines clinical research with cohort management, batch anonymization, and full clinical functionality-delivered as a cost-efficient and secure Software as a Service. Announcement • Nov 10
Sectra Launches Secure European Mobile Communication Platform for Sensitive But Formally Unclassified Information Sectra announced the launch of Sectra Tiger/E Managed Service-a sovereign, fully managed collaboration platform designed to meet the evolving needs of authorities, municipalities, essential entities, and corporations. The new solution enables secure, scalable, and easy-to-use mobile communication for sensitive but unclassified information. It supports calls, video, and chat with strong encryption, provides endpoint security, and is designed for high availability and broad usability. Sectra Tiger/E Managing Service combines hardened Samsung Knox devices, a dual-environment architecture, and a quantity-resilient VPN in a service model that strengthens national resilience. By separating two secure zones-one for sensitive collaboration and one for everyday tasks-the platform lets users work securely withoutosing usability or mobility. Altogether, the service ensures high availability, end-to-end encrypted communication, strong endpoint security and an infrastructure designed for national resilience and regulatory compliance. As it is a fully managed service by Sectra, it reduces the burden on internal IT teams and ensures the reliability essential for organizations that can't afford downtime. Designed to support both everyday sensitive communication and time-critical collaboration, Sectra Tiger/E Manage Service gives users the flexibility and mobility to work securely-whether handling business secrets, coordinating daily operations, or responding in a crisis. The solution is built on Sectra's long-standing experience in developing RESTRICTED, SECRET, and TOP SECRET solutions. While not intended for classified communication, it brings proven security practices and threat analysis methodology into a robust platform designed for sensitive collaboration. The Sectra Tiger/E (where "E" stands for "essentials") complements the suite of established solutions, such as Sectra Tiger/S (SECRET). In this context, "essentials" refers to information that requires enhanced security for sensitive communication and collaboration. Sectra Tiger/EManaged Service is available now to support organizations seeking to enhance security, ensure jurisdiction control, and enable encrypted collaboration in a rapidly changing threat landscape. Announcement • Sep 10
Sectra AB (Publ) Approves Ordinary Dividend, Payable on September 16, 2025 Sectra AB (publ) at its AGM held on September 9, 2025, approved ordinary dividend amounts to SEK 1.10 per share and the extra dividend to SEK 1.00 per share, representing a total of SEK 2.10 per share. The remaining earnings will be carried forward. The record date for entitlement to the dividend is September 11, 2025. The dividend is expected to be paid on September 16, 2025, through Euroclear Sweden AB. Announcement • Aug 13
Sectra Receives the Security Attestation Cloud Computing Compliance Criteria Catalogue (C5) for Its Software-As-A-Service Sectra has received the security attestation Cloud Computing Compliance Criteria Catalogue (C5) for its Software-as-a-Service (SaaS) for enterprise imaging, Sectra One Cloud. With Sectra being one of the first in the field in Germany to receive this attestation, healthcare providers are now able to adopt the cloud service and as such strengthen security and reduce IT burden. The C5 framework is created by Germany's national cybersecurity authority Bundesamt fur Sicherheit in der Informationstechnik (BSI), an authority that defines IT-Security requirements for all governmental systems in Germany. The attestation aims to strengthen the transparency and security of cloud-based solutions and contains a collection of requirements that defines what security measures a cloud service provider should have implemented to sell services handling patient data. Sectra One Cloud, which operates within the Microsoft Azure public cloud environment, now has both C5 and CSA STAR Level 2. While the CSA STAR Level 2 certificate, received in 2024, applies to global standards, the C5 attestation addresses requirements specific to the German market. Together, these certificates reflect Sectra's proactive leadership in advancing cloud security and transparency for the global healthcare market. Announcement • Jun 06
Sectra AB (publ), Annual General Meeting, Sep 09, 2025 Sectra AB (publ), Annual General Meeting, Sep 09, 2025. Board Change • Oct 20
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Employee Representative Deputy Director Alva Mardsjo was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Sep 06
First quarter 2025 earnings released: EPS: kr0.42 (vs kr0.32 in 1Q 2024) First quarter 2025 results: EPS: kr0.42 (up from kr0.32 in 1Q 2024). Revenue: kr739.5m (up 23% from 1Q 2024). Net income: kr80.4m (up 31% from 1Q 2024). Profit margin: 11% (in line with 1Q 2024). Revenue is forecast to grow 15% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Healthcare Services industry in Europe. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth. Reported Earnings • Jul 05
Full year 2024 earnings released: EPS: kr2.22 (vs kr1.95 in FY 2023) Full year 2024 results: EPS: kr2.22 (up from kr1.95 in FY 2023). Revenue: kr3.04b (up 26% from FY 2023). Net income: kr428.4m (up 14% from FY 2023). Profit margin: 14% (down from 16% in FY 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 15% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Healthcare Services industry in Europe. Over the last 3 years on average, earnings per share has increased by 13% per year whereas the company’s share price has increased by 17% per year. Reported Earnings • Jun 06
Full year 2024 earnings released: EPS: kr2.22 (vs kr1.95 in FY 2023) Full year 2024 results: EPS: kr2.22 (up from kr1.95 in FY 2023). Revenue: kr3.04b (up 26% from FY 2023). Net income: kr428.4m (up 14% from FY 2023). Profit margin: 14% (down from 16% in FY 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Healthcare Services industry in Europe. Over the last 3 years on average, earnings per share has increased by 13% per year whereas the company’s share price has increased by 16% per year. Announcement • Jun 06
Sectra AB (publ) to Report Fiscal Year 2025 Results on Jun 05, 2025 Sectra AB (publ) announced that they will report fiscal year 2025 results at 8:15 AM, Central European Standard Time on Jun 05, 2025 Announcement • Jun 05
Sectra Adds It Solution for Genomics in Cancer Diagnostics-First Deployment At A Us Health System Sectra launched a new diagnostic IT module for genomics within molecular pathology, developed in collaboration with the University of Pennsylvania Health System in the US. The new solution, now clinically live, enables hospitals to predict how an individual cancer patient may respond to different treatments based on genomic information. This will in turn have the potential to significantly impact patient care. The solution will be integrated with Sectra's other solutions for radiology and pathology. Analysis of genetic information, genomics, is increasingly used in healthcare to better diagnose and treat patients. Individualized care based on, among other data, genetic information is often referred to as precision medicine and is a rapidly growing field. The new solution from Sectra helps healthcare professionals analyze genetic information to enhance and speed up cancer diagnostics. The solution at Pennsylvania Health System is provided as a service, fully integrated with the medical record system, and Sectra takes full responsibility for the maintenance of the solution. This believes IT burdens at the health system and allows them to fully harness the potential and value of genomic data. It is now commercially available in the US, with the University of Pennsylvania Health system being the first to implement it. The IT solution for genomic information is, despite not being based on images, a part of Sectra's enterprise imaging solution. The enterprise imaging solution provides a unified strategy for all imaging and associated needs while lowering operational costs. The scalable and modular solution allows healthcare providers to grow from ology to ology and from enterprise to enterprise. Announcement • Apr 30
Sectra and Leica Biosystems Gains FDA Clearance to Utilize DICOM Images for Pathology Diagnostics Sectra together with Leica Biosystems, Imaging Inc.'s Aperio GT 450 DX have received a 510(k) clearance by the US Food & Drug Administration (FDA). This is the first time an FDA clearance within digital pathology allows the use of DICOM images for pathology diagnostics, which marks a significant step towards standardization in this field. Sectra received its first FDA clearance during the pandemic, in 2020. The pandemic made the need and value of remote work even in the field of pathology obvious and has helped boost the adoption of digital pathology in the US. Today, the value of accessing, sharing and reviewing digital images is clear and the market for digital pathology in the US, as well as other countries, is growing rapidly. The FDA clearance includes: Sectra's digital pathology solution when used with Leica Biosystems Aperio GT 450 DX. SVS and DICOM file formats. Sectra UniView and IDS7 cloud-based and on-premises installation. A digital pathology solution provides instant and, if necessary, remote access to digital images of tissue samples instead of relying on physical glass slides reviewed in microscopes. This optimizes the workflows for pathologists, leading to enhanced efficiency in cancer diagnostics. The pathology solution is part of Sectra's enterprise imaging solution, which provides a unified strategy for all imaging needs while lowering operational costs. The scalable and modular solution, with a VNA at its core, allows healthcare providers to grow from ology to ology and from enterprise to enterprise. Reported Earnings • Mar 10
Third quarter 2024 earnings released: EPS: kr0.30 (vs kr0.38 in 3Q 2023) Third quarter 2024 results: EPS: kr0.30 (down from kr0.38 in 3Q 2023). Revenue: kr714.0m (up 20% from 3Q 2023). Net income: kr57.8m (down 20% from 3Q 2023). Profit margin: 8.1% (down from 12% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 5.9% growth forecast for the Healthcare Services industry in Europe. Over the last 3 years on average, earnings per share has increased by 15% per year whereas the company’s share price has increased by 17% per year. Announcement • Mar 08
Sectra AB (publ) to Report Q1, 2025 Results on Sep 06, 2024 Sectra AB (publ) announced that they will report Q1, 2025 results at 8:15 AM, Central European Standard Time on Sep 06, 2024 Valuation Update With 7 Day Price Move • Dec 22
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to €15.91, the stock trades at a forward P/E ratio of 82x. Average forward P/E is 26x in the Healthcare Services industry in Europe. Total returns to shareholders of 8.8% over the past three years. Announcement • Dec 21
Sectra AB (publ), Annual General Meeting, Sep 10, 2024 Sectra AB (publ), Annual General Meeting, Sep 10, 2024. Reported Earnings • Dec 16
Second quarter 2024 earnings released: EPS: kr0.78 (vs kr0.49 in 2Q 2023) Second quarter 2024 results: EPS: kr0.78 (up from kr0.49 in 2Q 2023). Revenue: kr807.9m (up 41% from 2Q 2023). Net income: kr150.6m (up 60% from 2Q 2023). Profit margin: 19% (up from 16% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 8.8% p.a. on average during the next 3 years, compared to a 8.6% growth forecast for the Healthcare Services industry in Europe. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. Upcoming Dividend • Oct 19
Upcoming dividend of kr1.10 per share at 0.9% yield Eligible shareholders must have bought the stock before 23 October 2023. Payment date: 27 October 2023. Trailing yield: 0.9%. Lower than top quartile of German dividend payers (5.0%). Lower than average of industry peers (1.6%). Reported Earnings • Sep 06
First quarter 2024 earnings released First quarter 2024 results: Revenue: kr603.0m (up 22% from 1Q 2023). Net income: kr61.6m (up 14% from 1Q 2023). Profit margin: 10% (in line with 1Q 2023). Reported Earnings • Jul 07
Full year 2023 earnings released: EPS: kr1.95 (vs kr1.63 in FY 2022) Full year 2023 results: EPS: kr1.95 (up from kr1.63 in FY 2022). Revenue: kr2.41b (up 21% from FY 2022). Net income: kr375.0m (up 19% from FY 2022). Profit margin: 16% (in line with FY 2022). New Risk • Jun 08
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. Announcement • Jun 03
Sectra AB (Publ) Proposes Dividend The Board of Directors and President of Sectra AB (publ) have proposed that the Annual General Meeting (AGM) resolve that SEK 1.10 SEK per share be distributed to the shareholders through a share redemption program. Reported Earnings • Jun 02
Full year 2023 earnings released: EPS: kr1.95 (vs kr1.63 in FY 2022) Full year 2023 results: EPS: kr1.95 (up from kr1.63 in FY 2022). Revenue: kr2.41b (up 21% from FY 2022). Net income: kr375.0m (up 19% from FY 2022). Profit margin: 16% (in line with FY 2022). Reported Earnings • Mar 11
Third quarter 2023 earnings released Third quarter 2023 results: Revenue: kr595.5m (up 23% from 3Q 2022). Net income: kr72.3m (up 15% from 3Q 2022). Profit margin: 12% (in line with 3Q 2022). Revenue is forecast to grow 9.2% p.a. on average during the next 2 years, compared to a 9.0% growth forecast for the Healthcare Services industry in Europe. Announcement • Dec 20
Sectra AB (publ), Annual General Meeting, Sep 07, 2023 Sectra AB (publ), Annual General Meeting, Sep 07, 2023. Reported Earnings • Dec 18
Second quarter 2023 earnings released Second quarter 2023 results: Revenue: kr573.6m (up 33% from 2Q 2022). Net income: kr93.9m (up 42% from 2Q 2022). Profit margin: 16% (up from 15% in 2Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 10% p.a. on average during the next 2 years, compared to a 9.0% growth forecast for the Healthcare Services industry in Europe. Announcement • Sep 09
Sectra AB (Publ) Elects Ulrika Unell to the Board Sectra AB (publ) announced that at its AGM held on September 8, 2022, shareholders elected Ulrika Unell to the Board. Reported Earnings • Sep 03
First quarter 2023 earnings released First quarter 2023 results: Revenue: kr493.2m (up 18% from 1Q 2022). Net income: kr54.1m (down 26% from 1Q 2022). Profit margin: 11% (down from 18% in 1Q 2022). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 14%, compared to a 15% growth forecast for the Healthcare Services industry in Germany. Announcement • Aug 16
Sectra Launches Next Generation Cloud Portal to Enhance Clinical Learning in Medical Education Sectra launched a new generation of its cloud-based teaching platform Sectra Education Portal. It will greatly enhance students' learning outside the classroom with significant improvements in usability and functionality. Aligned with Sectra's overall commitment to deliver cloud-first software, it will facilitate for the hundreds of medical schools using the platform to bridge the gap between education and their students' professional careers. A growing need for care along with a rapid increase in medical knowledge is creating challenges when it comes to training healthcare personnel effectively. Managing these challenges requires new ways of working and new tools in medical education. The digital tools and actual patient cases in Sectra Education Portal help create a bridge between training and healthcare. When students can realistically interact with patient cases, it creates deeper understanding of and insight into anatomy as well as the body's functions and processes. This improves the learning process and helps students develop their analytical and problem-solving skills. Reported Earnings • Jul 08
Full year 2022 earnings released: EPS: kr1.63 (vs kr1.43 in FY 2021) Full year 2022 results: EPS: kr1.63 (up from kr1.43 in FY 2021). Revenue: kr1.99b (up 19% from FY 2021). Net income: kr314.8m (up 14% from FY 2021). Profit margin: 16% (in line with FY 2021). Over the next year, revenue is forecast to grow 13%, compared to a 90% growth forecast for the industry in Germany. Reported Earnings • Jun 04
Full year 2022 earnings released: EPS: kr1.63 (vs kr1.43 in FY 2021) Full year 2022 results: EPS: kr1.63 (up from kr1.43 in FY 2021). Revenue: kr1.99b (up 19% from FY 2021). Net income: kr314.8m (up 14% from FY 2021). Profit margin: 16% (in line with FY 2021). Over the next year, revenue is forecast to grow 11%, compared to a 22% growth forecast for the industry in Germany. Announcement • Jun 03
Sectra AB (Publ) Proposes Dividend The Board of Directors and President of Sectra AB (publ) have proposed that the 2022 Annual General Meeting (AGM) resolve to distribute SEK 1.00 (0.90) per share to the shareholders through a share redemption program. Board Change • Apr 27
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Employee Representative Deputy Board Member Pontus Svard was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Mar 10
Third quarter 2022 earnings: Revenues exceed analyst expectations Third quarter 2022 results: Net income: kr62.9m (up 18% from 3Q 2021). Revenue exceeded analyst estimates by 7.0%. Recent Insider Transactions • Dec 16
Independent Director recently bought €91k worth of stock On the 14th of December, Birgitta Hagenfeldt bought around 5k shares on-market at roughly €18.11 per share. This was the largest purchase by an insider in the last 3 months. Despite this recent purchase, insiders have collectively sold €151k more in shares than they bought in the last 12 months. Reported Earnings • Dec 12
Second quarter 2022 earnings: Revenues miss analyst expectations Second quarter 2022 results: Revenue: kr432.2m (up 1.7% from 2Q 2021). Net income: kr66.3m (down 8.8% from 2Q 2021). Profit margin: 15% (down from 17% in 2Q 2021). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 5.3%. Over the next year, revenue is forecast to grow 16%, compared to a 59% growth forecast for the industry in Germany. Board Change • Dec 11
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Employee Representative Deputy Board Member Pontus Svard was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Board Change • Oct 31
High number of new directors Employee Representative Director Filip Klintenstedt was the last director to join the board, commencing their role in 2020. Reported Earnings • Sep 05
First quarter 2022 earnings released: EPS kr1.90 (vs kr0.44 in 1Q 2021) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: kr417.3m (up 35% from 1Q 2021). Net income: kr73.1m (up 334% from 1Q 2021). Profit margin: 18% (up from 5.5% in 1Q 2021). The increase in margin was driven by higher revenue. Reported Earnings • Jul 04
Full year 2021 earnings released: EPS kr7.15 (vs kr6.18 in FY 2020) The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: kr1.68b (down 1.4% from FY 2020). Net income: kr275.5m (up 16% from FY 2020). Profit margin: 16% (up from 14% in FY 2020). The increase in margin was driven by lower expenses. Reported Earnings • Jun 04
Full year 2021 earnings released: EPS kr7.15 (vs kr6.18 in FY 2020) The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: kr1.68b (down 1.4% from FY 2020). Net income: kr275.5m (up 16% from FY 2020). Profit margin: 16% (up from 14% in FY 2020). The increase in margin was driven by lower expenses. Recent Insider Transactions • Mar 23
Chief Financial Officer recently bought €12k worth of stock On the 15th of March, Mats Franzén bought around 200 shares on-market at roughly €60.35 per share. This was the largest purchase by an insider in the last 3 months. This was Mats' only on-market trade for the last 12 months. Reported Earnings • Mar 14
Third quarter 2021 earnings released: EPS kr1.39 (vs kr2.06 in 3Q 2020) The company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2021 results: Revenue: kr407.7m (down 14% from 3Q 2020). Net income: kr53.3m (down 33% from 3Q 2020). Profit margin: 13% (down from 17% in 3Q 2020). The decrease in margin was driven by lower revenue. Analyst Estimate Surprise Post Earnings • Mar 14
Revenue misses expectations Revenue missed analyst estimates by 12%. Over the next year, revenue is forecast to grow 17%, compared to a 13% growth forecast for the Medical Equipment industry in Germany. Announcement • Mar 12
Sectra Signs Five-Year Enterprise Imaging Contract with Emory Healthcare in the US Sectra will install its enterprise imaging solution at Emory Healthcare. The contract, signed in February, includes modules for radiology and all imaging subspecialties, orthopedics, and image archiving. Patient linking will be set up with sister institution, Grady Health System, to ensure physicians at both locations have access to shared patient images and reports. The enterprise subscription contract, in addition to the aforementioned products, will include advanced visualization, a zero-footprint viewer, business analytics/real-time dashboard, teaching files, and tumor board capabilities. Emory Healthcare, part of Emory University, is the most comprehensive academic health care system in Georgia. It is made up of 11 hospitals, Emory Clinic, and more than 250 provider locations. The Emory Healthcare Network, established in 2011. Announcement • Mar 10
Quantum-Proof Crypto from Sectra Receives SECRET Approval from EU The EU council has approved the latest version of the eavesdrop-proof mobile phone Sectra Tiger/S 7401 LTE from Sectra. This approval, which applies to the security level SECRET, certifies the latest Sectra Tiger/S version for sharing information that, if it fell into the wrong hands, could severely damage the security of the EU and its member nations. Sectra Tiger/S is quantum-proof, and the latest version includes features such as improved file transfer and chat as well as support for all fixed and mobile 4G networks within Europe. These new features provide the user with improved availability, while also enhancing the user experience and areas of application. The voice and file transfer features are approved for use up to and including the security level SECRET UE/EU SECRET. The messaging feature is approved for use up to and including RESTREINT UE/EU RESTRICTED. Quantum computers have the capability to perform certain types of calculations much more efficiently than today's computers. Such computers could thus pose a threat to current encryption methods, and quantum-safe solutions are therefore perceived to be one of the key traits of future-proof confidentiality. Is New 90 Day High Low • Mar 03
New 90-day low: €65.40 The company is down 2.0% from its price of €67.00 on 03 December 2020. The German market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Medical Equipment industry, which is up 16% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €16.74 per share. Announcement • Feb 10
EU Orders Sectra Tiger Solution for Sharing Classified Information Several EU institutions have procured additional units of the Sectra Tiger mobile encryption system from international cybersecurity and medical imaging IT company Sectra. The Sectra Tiger system will ensure that users are able to securely and efficiently communicate classified information up to and including the EU SECRET security level, with full availability anywhere and at any time. The European Union has worked together with Sectra since 2010. Through the procurement of additional units, the EU institutions are extending their use of the Sectra Tiger system, a secure communication solution that allows users to share classified information up to the SECRET security level. Unique features in the Sectra Tiger system allow users to communicate securely between different organizations and security levels, without risking the confidentiality of the information, while ensuring the integrity of each security domain. Announcement • Jan 22
Sectra AB (Publ) Receives an Order for its Digital Pathology Solution from Amsterdam UMC in the Netherlands Sectra AB (publ) has received an order for its digital pathology solution from Amsterdam UMC in the Netherlands. This follows a recently announced radiology imaging contract. With radiology and pathology in one joint solution, Amsterdam UMC will be able to conveniently share images and information between the two medical specialties, enabling efficient integrated diagnostics and improved patient-centric care. One of the main benefits of digitizing pathology is the ability to share digital images, rather than sending physical slides back and forth. This helps healthcare providers reduce treatment errors as well as logistics and administration, resulting in potential savings. Access to specialists for efficient external readings and second opinions can also cut waiting times for patients-helping pathology to meet patient demand and regulatory enforcements. Sectra's digital pathology solution will be integrated with the laboratory information system (LIS) used at Amsterdam UMC. This will provide pathologists with a complete overview of the patient history in one application and enable workflow orchestration to drive the workflow according to sub-specialties, rules and priorities. The solution's vendor-neutral approach also enables Amsterdam UMC to use the scanner vendor of its choice. The contract was signed during the third quarter of Sectra's fiscal year 2020/2021. Announcement • Jan 20
Sectra Receives Order from Institut Bergonié Sectra has received an order from Institut Bergonié for its digital pathology solution. The solution will enable pathologists to review and collaborate around cases in a manner previously not possible using a microscope. It reduces variation and increases efficiency, thereby improving care for cancer patients. Announcement • Jan 14
Healthcare Region Pioneering Digital Pathology Reviews in Denmark with Sectra-Aims to Significantly Shorten Cancer Turn-Around Times The healthcare provider Region of Southern Denmark has gone live with a digital pathology solution from international medical imaging IT and cybersecurity company Sectra. The IT solution makes it possible for pathologists at the region's four hospitals to review and collaborate around cases in a way that is not possible with microscopes. This supports increased efficiency in primary diagnostics, thereby improving cancer care. The Region of Southern Denmark is the first Danish healthcare region to digitize pathology in full scale. With Sectra's digital pathology solution, resource utilization and sub-specialization can be optimized at the region's four geographically dispersed hospitals. This enables the region to provide all patients with equal access to healthcare services, regardless of their location. Digitizing pathology brings pathologists new functionality beyond the microscope. Without the need for physical glass slides, digital access enables them to instantly access and share current and historical images and information between departments and hospitals as well as the possibility to benefit from evolving technology such as AI. The digital solution provides pathologists with assistance at critical decision points, such as grading or performing more precise measurements. It also enables image analysis, which in turn reduces variation and improves the precision of tasks such as cell counting. Digital access further facilitates second opinions, external reading resources, and specialist consultations. Announcement • Jan 12
The Pennine Acute Hospitals NHS Trust Deploys the Imaging IT Solution from Sectra The Pennine Acute Hospitals NHS Trust has become the first of eight NHS trusts in the UK to deploy the imaging IT solution from international medical imaging IT and cybersecurity company Sectra. This follows the announcement of the enterprise imaging contract in October 2020. The go-live is transforming how clinical staff examine crucial patient images. Faster diagnoses for millions of people, new possibilities around AI, and region-wide collaboration are just some of the benefits that will follow. A new region-wide approach to analyzing x-rays, MRI scans, CT scans, mammography, and an entire range of crucial diagnostic images has started to become reality, now that The Pennine Acute has become the first of eight trusts across Greater Manchester to deploy medical imaging technology. Healthcare professionals at the trust have begun using a new enterprise imaging solution to benefit patients only weeks after the Greater Manchester Provider Federation Board signed a landmark contract with Sectra in October 2020. The agreement represents one of the largest imaging initiatives of its kind in the NHS and anywhere in Europe. This news at Pennine Acute is regarded as the first step in an initiative that will transform the way patients are diagnosed and treated. The imaging solution (PACS) is used by hospital staff to review patient images digitally. It replaces ageing IT and is already delivering immediate benefits to staff such as being able to view and report on detailed images remotely, including from their homes. In the case of surgical scenarios, 3D orthopedic tools will allow staff to virtually reconstruct joints prior to procedures. And the system is expected to transform how multidisciplinary teams function. The biggest wins from the initiative are expected as an accelerated delivery program expands the new PACS and an accompanying multimedia system known as a vendor neutral archive (VNA), both supplied by Sectra, across Greater Manchester. Once the solution is live and rolled out in more hospitals, clinical staff will be able to instantly access patient images captured at any of the participating NHS trusts in the region. This will support healthcare professionals making decisions at the point of care and help staff carrying out reports used to inform diagnoses. The program paves the way for better and faster access to scarce expertise and faster diagnoses for 3.2 million people across Greater Manchester at a time of national staff recruitment challenges in specialist disciplines like radiology. The Pennine Acute consists of hospitals in Oldham, Bury, Rochdale and North Manchester. The Oldham, Bury and Rochdale sites are managed along with Salford Royal NHS Foundation Trust as the Northern Care Alliance. The North Manchester site is managed as part of the Manchester University NHS Foundation Trust Group. Announcement • Dec 12
Norwegian Healthcare Region Appoints Sectra as Enterprise Imaging Vendor for Efficient Region-Wide Patient Care Sectra has secured an enterprise imaging contract from the South-Eastern Norway Regional Health Authority. The contract comprises a radiology module and a region-wide multimedia solution (VNA) to store medical images and multimedia across all medical specialties. The platform will increase efficiency and collaboration across the region and beyond, translating into improved healthcare for its patients. South-Eastern Norway Regional Health Authority is the largest of the four healthcare regions in Norway and provides healthcare to approximately three million people. Initially, the radiology module will be implemented at Oslo University Hospital and the intention is for the other healthcare providers in the region to follow. The region-wide solution will provide healthcare professionals access to medical images and information regardless of the enterprise boundaries. It enables regional standardized work processes and patient processes. The solution will also be deeply integrated with the region's Electronic Patient Record (EPR) solution to provide the care teams with a full patient overview. The contract comprises a module for radiology and nuclear medicine, a multimedia archive (VNA) to store medical images and multimedia across all medical specialties, in addition to functionality to share and collaborate efficiently and for patient dose reporting to the authorities. Though Sectra has been selected as vendor of choice by South-Eastern Norway Regional Health Authority the formal contract is subject to final signatures which are expected before end of December. Sectra's enterprise imaging solution provides a unified strategy for all imaging needs while lowering operational costs. The scalable and modular solution, with a VNA at its core, allows healthcare providers to grow from ology to ology and from enterprise to enterprise. Recent Insider Transactions • Dec 10
Insider recently bought €10.0k worth of stock On the 2nd of December, Gustaf Schwang bought around 150 shares on-market at roughly €66.59 per share. This was the largest purchase by an insider in the last 3 months. Despite this recent purchase, insiders have collectively sold €468k more in shares than they bought in the last 12 months. Announcement • Dec 04
Sectra Signs Subscription-Based Enterprise Imaging Contract with Dayton Children's Hospital in US Sectra provide its enterprise imaging solution to Dayton Children's Hospital. They will utilize the platform's radiology and cardiology modules as well as the multi-media archive VNA, to store all medical images throughout the health system. This unified imaging platform, tightly integrated with Epic Radiant, will provide all caregivers a full patient overview regardless of their reading location. Dayton Children's is a teaching hospital providing primary and subspecialty ambulatory and acute inpatient care for Dayton, Ohio, and its 20-county service area. In addition to its 181-bed main campus hospital, it has 12 outpatient locations providing emergent, urgent, and routine care. The contract, signed in October, provides enterprise imaging as a subscription service (Sectra One). This will allow Dayton Children's the ability to easily expand into other specialties and gain access to new functionality, as it becomes available. Acquiring enterprise imaging as a subscription provides a more efficient way of scaling the system as volumes grow. company's enterprise imaging solution provides a complete and robust system armed with efficient and accurate clinical tools, proven to boost productivity and improve collaboration. The scalable and modular solution, with a VNA at its core, allows healthcare providers to grow from ology to ology and from enterprise to enterprise. The offering includes a module for full-scale digital pathology, which received FDA approval in the US in March 2020. Announcement • Dec 02
Sectra and RSA Biomedical sign distribution agreement for Sectra's CT-based method for clinical validation of orthopaedic implant stability Sectra has signed a distribution agreement with RSA Biomedical. Under the contract, RSA Biomedical will now offer Sectra CT-based Micromotion Analysis (Sectra CTMA®). This measurement method facilitates time and cost-efficient clinical validation of orthopaedic implant movement for the benefit of patient safety. Sectra CTMA is a method that facilitates the measurement of movements between implants and bone using computed tomography images (CT images). The method uses CT images taken typically up to two years after implantation to measure the 3D movement of an implant or bone fragment on a submillimeter scale. With this data, scientists can analyze the movement of an implant or bone segment over time. This early high-precision information provides a strong predictor of the long-term survival of the implant. Reported Earnings • Nov 28
Second quarter 2021 earnings released: EPS kr1.89 The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: kr424.8m (up 14% from 2Q 2020). Net income: kr72.7m (up 108% from 2Q 2020). Profit margin: 17% (up from 9.4% in 2Q 2020). The increase in margin was driven by higher revenue. Analyst Estimate Surprise Post Earnings • Nov 28
Revenue beats expectations Revenue exceeded analyst estimates by 21%. Over the next year, revenue is forecast to grow 6.3%, compared to a 11% growth forecast for the Medical Equipment industry in Germany. Announcement • Nov 17
Sectra to Add its Digital Pathology Module to the Sectra Enterprise Imaging Solution Sectra will add its digital pathology module to the Sectra enterprise imaging solution located throughout MetroHealth. This will enable pathologists to read cases from any location, including their homes, and allow for streamlined tumor board meetings and improved cancer care for patients. The initial implementation will focus on the development of workflows around quality assurance within pathology, seamless integration of pathology with tumor boards, and a teaching and research database for the 13 pathologists and 9 residents at MetroHealth. Efficiencies in these workflows will improve the ability of pathologists to actively participate in patient management teams. The contract was signed in October 2020. MetroHealth's staff of 7,800 employees provides care at 4 hospitals, 20 health centers, and 40 additional sites in Northeast Ohio. Each active physician holds a faculty appointment at Case Western Reserve University School of Medicine. Sectra's pathology module received FDA approval in the US in March 2020 and is part of Sectra's enterprise imaging offering. It provides a unified strategy for all imaging needs while lowering operational costs. The scalable and modular solution, with a VNA at its core, allows healthcare providers to grow from ology to ology and from enterprise to enterprise. Announcement • Nov 12
Sectra Signs A Digital Pathology Contract with the Helse Vest Sectra announced it has signed a digital pathology contract with the Norwegian healthcare region Helse Vest RHF. The healthcare region already uses Sectra's enterprise imaging solution, which will now include digital pathology. The region-wide solution allows Helse Vest to share resources among healthcare providers, and using the same system for multiple diagnostic specialties enables integrated diagnostics, which is key for efficient cancer care. The solution will be integrated with the laboratory information system (LIS) at Helse Vest. Tight integration between Sectra's solution and the LIS will provide the pathologists with a complete overview of the patient history, in one application and enable an efficient workflow based, for example, on sub-specialization and priority. The solution's vendor-neutral approach gives Helse Vest freedom of choice in selecting a scanner vendor. Using digital images of tissue samples rather than physical glass slides, pathologists can access and share current and historical images and information from anywhere and at any time. This digital solution provides pathologists with assistance at critical decision points, such as grading or performing more precise measurements. The solution from Sectra also enables additional image analysis, both through its proprietary solution for cell counting and through integration with third-party solutions. Digital access also facilitates second opinions, external reading resources and specialist consultations, in addition to making integrated diagnostics possible. Helse Vest has used Sectra's enterprise imaging solution for many years to store all types of medical images and multimedia, and has used the radiology module to manage images and patient information throughout the region. With this digital pathology contract, signed in November 2020, the solution will also include approximately 100,000 pathology examinations per year. Sectra's enterprise imaging solution provides a unified strategy for all imaging needs while lowering operational costs. The scalable and modular solution, with a VNA at its core, allows healthcare providers to grow from ology to ology and from enterprise to enterprise. Announcement • Nov 09
Sectra Deploys Its Software for Medical Imaging At Leeds Teaching Hospitals Sectra has deployed its software for medical imaging at Leeds Teaching Hospitals. It is the first of an initial six trusts in the Northern Pathology Imaging Co-operative (NPIC) to go live, paving the way for one of the most sophisticated interconnected pathology initiatives in the world. The technology from Sectra will underpin the regional program that is digitizing, connecting and applying artificial intelligence to pathology services in the North of England. Leeds Teaching Hospitals went live with Sectra's solution for digital pathology and Vendor Neutral Archive (VNA) in October. This will allow pathology images to be interrogated by professionals electronically from a range of devices-anywhere and at any time. With many pathology departments across the country still reliant on microscopes and glass slides, the new system is allowing pathologists to work more quickly, gain easier access to opinions from colleagues and manage rising demand. Furthermore, the joint VNA will allow the trust to pool imaging and build a platform for artificial intelligence that is crucial to improving diagnoses for cancer and other illnesses. Announcement • Nov 07
Sectra's Digital Pathology Solution Used in Training of Pathologists in Australasia The Royal College of Pathologists of Australasia (RCPA) has reached a milestone in its exam process with trainees now using the digital pathology solution from Sectra. This provides trainees across the region with easy-to-use tools that enable them to focus on the pathology cases at hand. Sectra's solution will be used by pathology trainees from across Australasia, including Australia, New Zealand, Hong Kong, Singapore, Malaysia and Saudi Arabia, during their final pathology exams. The trainees will have access to Sectra's solution through the program portal where they will receive cases and associated questions for assessment. The solution's zero-footprint viewer and smart streaming functionality enable access to digital pathology images without large installations, at any time. Announcement • Oct 19
Amsterdam UMC Chooses Sectra for Enterprise-Wide Radiology Imaging Sectra has signed a seven-year contract with one of the large healthcare providers in the Netherlands - Amsterdam UMC. Sectra will install its imaging solution throughout the radiology and nuclear medicine departments to boost reading and reporting efficiency and enhance collaboration across its two hospitals. Amsterdam UMC is the result of a merger in 2018 of the Academic Medical Center (AMC) and the VU University Medical Center (VUmc). With Sectra's solution, the two hospitals will now also merge and consolidate their radiology and nuclear medicine IT systems into one. The radiologists will carry out both reading and reporting directly in the Sectra solution. As the native reporting module supports both rich and structured reporting, the radiologists will be able to perform reporting close to the images, giving a rich report back to the referring physician all without the need of switching applications. The contract, signed in September, comprises radiology imaging, including nuclear medicine, and business analytics. The solution will handle approximately 350,000 examinations per year. The radiology solution purchased by Amsterdam UMC is part of Sectra's enterprise imaging offering, which provides a unified strategy for all imaging needs while lowering operational costs. The scalable and modular enterprise imaging solution, with a VNA at its core, allows healthcare providers to grow from ology to ology and from enterprise to enterprise. 
